 |
|
Influence of Serotonin Transporter Promoter Region Polymorphisms on Hippocampal Volumes in Late-Life Depression
Warren D. Taylor, MD;
David C. Steffens, MD;
Martha E. Payne, MPH, RD;
James R. MacFall, PhD;
Douglas A. Marchuk, PhD;
Ingrid K. Svenson, PhD;
K. Ranga R. Krishnan, MD
Arch Gen Psychiatry. 2005;62:537-544.
ABSTRACT
| |
Context Polymorphisms in the promoter region of the serotonin transporter gene (5-HTTLPR) influence transcription and may play a role in the pathogenesis and course of depression. Recent research demonstrates that specific polymorphisms may be associated with differences in hippocampal volumes in subjects with depression.
Objective To examine associations between 5-HTTLPR genotype and hippocampal volumes in elderly control subjects and elderly subjects classified as having early or late onset of depression.
Design Cohort study examining baseline characteristics.
Participants Subjects were community dwelling and 60 years or older. Using a definition of early-onset depression as depression first occurring at 50 years or younger, we examined 72 subjects with early-onset depression, 63 subjects with late-onset depression, and 83 healthy control subjects.
Main Outcome Measures All subjects underwent genotyping for the 5-HTTLPR and underwent brain magnetic resonance imaging. Analyses of hippocampal volumes were controlled for total cerebral volume, age, and sex.
Results The interaction between diagnosis and 5-HTTLPR genotype was statistically significant for the right hippocampus (P = .04). Subjects with late-onset depression who were homozygous for the long (L) allele (L /L genotype) had significantly smaller right hippocampal volumes than did L /L subjects with early-onset depression (P = .046) or L /L control subjects (P = .01). Post hoc analyses showed that later age of depression onset was associated with smaller hippocampal volumes in subjects with the L /L genotype, but earlier age of onset was associated with smaller hippocampal volumes in subjects who were homozygous for the short (S) allele (S/S genotype).
Conclusions Subjects with late-onset depression who were homozygous for the L allele exhibited smaller hippocampal volumes than other groups. Genotype also mediated the effect of age of onset on hippocampal volumes. Our findings differ from previous work; however, we examined an older and larger cohort of subjects than previous studies. Possible explanations for these findings include interactions between the serotonergic system and neurotrophic factors or cortisol response to stresses, each of which may affect hippocampal volumes.
INTRODUCTION
The hippocampus plays a significant role in mood regulation with neural connections to key brain regions, including the thalamus, amygdala, basal ganglia, and prefrontal cortex.1-3 Structural imaging studies examining hippocampal volumes in adult populations with depression have been mixed; some report that volumes are smaller in cohorts with depression,4-9 while others did not demonstrate a difference.10-12 A more consistent finding is that smaller hippocampal volumes are seen in subjects with recurrent depression6, 13 or earlier age of depression onset,5-6,10, 13-14 suggesting that duration of depression, particularly untreated depression,14 may impact hippocampal volumes.
Similar results are seen in studies focused on geriatric populations. Some have found that geriatric depression and early age of depression onset are associated with smaller hippocampal volumes,15-16 but others have not found such relationships.17-18 Smaller hippocampal volumes also appear to be associated with a lower likelihood of experiencing remission of depression with treatment.19 Complicating the matter, smaller left hippocampal volumes are associated with increased risk of dementia.20
Differences in the genotype of the serotonin transporter–linked promoter region (5-HTTLPR) have been associated with hippocampal volumes21 and may explain some of the conflicting results of studies investigating the hippocampus in depression. This polymorphism in the promoter region of the serotonin transporter gene contains a 44-base pair (bp) insertion (long, or L allele) or deletion (short, or S allele). When compared with the L allele, the S allele is associated with a lower level of serotonin uptake and transcriptional efficiency of the serotonin transporter,22-23 which may play a role in depression.24 Although some have found that allelic differences may be susceptibility factors for depression25 or are associated with depression subtypes,26 others have found no association between depression and different genotypes.27-31 In subjects with depression, there does appear to be an association between subjects with S alleles and poorer response to antidepressants,30, 32-33 increased adverse effects to serotonin reuptake inhibitors,34 and increased risk of suicide attempts.29, 35
In an attempt to bridge neuroanatomical correlates of depression and mood regulation with genetic contributors to depression, a recent study examined the relationship between 5-HTTLPR genotype and hippocampal volumes.21 The authors found that subjects with depression who were homozygous for the L allele (L /L genotype) had smaller hippocampal volumes than did controls with the L /L genotype; similar relationships were not found for other genotypes. They proposed that reduced hippocampal volumes in this genotype may be a risk factor for rather than a consequence of major depression. We sought to replicate this finding in a cohort of elderly subjects with depression and elderly control subjects without depression and expand it to examine for differences based on age of depression onset.
METHODS
SAMPLE
Subjects with depression were participants in the National Institute of Mental Health Conte Center for the Neuroscience of Depression in Late Life, located at Duke University, Durham, NC. The Conte Center operates in a naturalistic treatment milieu and screens for both incident and prevalent cases. Eligibility was limited to patients 60 years or older with a diagnosis of unipolar major depression. Exclusion criteria included (1) another major psychiatric illness; (2) alcohol or drug dependence; (3) primary neurologic illness, including dementia; (4) illness or medication precluding cognitive testing; and (6) metal in the body precluding magnetic resonance imaging (MRI).
Control subjects were community dwellers recruited from the Aging Center Subject Registry at Duke University. Eligible control subjects had a nonfocal neurologic examination, no self-report of neurologic or depressive illness, and no evidence of a depression diagnosis based on the National Institute of Mental Health Diagnostic Interview Schedule.36
A trained interviewer administered the Duke Depression Evaluation Schedule37 (DDES) to each subject. The DDES, a composite diagnostic interview instrument, includes sections of the National Institute of Mental Health Diagnostic Interview Schedule36 assessing depression, enriched with items assessing sleep problems and the clinical features of melancholia and psychosis, dysthymia, mania, and alcohol abuse or dependence. The DDES also includes the Montgomery-Asberg Depression Rating Scale38 and questions on age of depression onset.
The study protocol was approved by the Duke University Medical Center institutional review board. All subjects provided written informed consent before beginning study procedures.
We have previously published data examining hippocampal volumes in a smaller sample16 and examined differences in the 5-HTTLPR in a larger sample31 than reported herein. To participate in this study, subjects had to have both genetic and MRI data.
MRI ACQUISITION AND ANALYSIS
All subjects were screened for any condition where MRI was contraindicated. Subjects were imaged with a 1.5-T, whole-body MRI system (Signa; GE Medical Systems, Milwaukee, Wis) using the standard head (volumetric) radiofrequency coil. Padding immobilized the head. The scanner alignment light was used to adjust the head tilt and rotation so that the axial-plane lights passed across the canthomeatal line, and the sagittal lights were aligned with the center of the nose. A rapid sagittal localizer scan was acquired to confirm the alignment.
Two sets of dual-echo, fast spin-echo acquisitions were obtained: one in the axial plane for morphometry of cerebral structures and a second in a coronal oblique plane for segmentation of the hippocampus. The pulse sequence parameters were repetition time = 4000 milliseconds, echo time = 30 and 135 milliseconds, 32-kHz (± 16-kHz) full-imaging bandwidth, echo train length = 16, a 256 x 256 matrix, 3-mm section thickness, 1 number of excitations, and a 20-cm field of view. The images were acquired in 2 separate acquisitions with a 3-mm gap between sections for each acquisition. The second acquisition was offset by 3 mm from the first so that the resulting data set consisted of contiguous sections. For the near coronal acquisition, the localizer scan was used to identify the anterior commissure–posterior commissure line. Oblique, near-coronal images were prescribed perpendicular to this line, covering the entire brain from just anterior of the temporal lobe to a plane posterior to the lateral ventricles.
The GRID program was used to quantify the hippocampus; methods for delineating the hippocampus have previously been described.16 This program allows for semiautomated determination of region of interest volumes and was based on a manual point-counting method.39 The program used a single magnetic resonance contrast, creating a histogram of the image intensities. The analyst moved tissue-type pointers on the histogram to preassign tissue types in the image. A grid of a size chosen by the operator was then superimposed on the image with the tissue type at each intersection preassigned by the adjusted histogram. Working with an original image series, the analyst efficiently readjusted the intensity cutoffs (histogram) for each tissue type, as well as the size of the grid. If any regions were misclassified, individual grid points were changed to the correct tissue type. A combination of this tissue classification with manual tracing allowed for rapid determination of region of interest volumes.
The hippocampus was defined as follows.16 On each scan, analysts began with the most posterior coronal slice and moved anteriorly. Measurement of the hippocampus on each side began when the pulvinar nucleus of the thalamus obscured the crura fornicis. The fimbria, which extends from the superior surface of the hippocampus across the cerebrospinal fluid into the white matter above, was transected at its narrowest point. Along the medial border of the hippocampus, the thin strip of gray matter was cut at its narrowest point, and tracing then continued around the hippocampal body to the starting point. The amygdala-hippocampal transition zone appeared as a diffuse area of gray matter between the anterior portion of the hippocampus and the posterior portion of the amygdala; this area was also transected at its narrowest point, usually found between the inferior lateral ventricles and the cistern. The anterior border of the hippocampus was defined as the slice on which the inferior lateral ventricle appeared horizontally without any body of gray matter visible below it.
Total cerebral volume was measured using a Duke University Medical Center Neuropsychiatric Imaging Research Laboratory–modified version of MRX Software, created by GE Corporate Research and Development (Schenectady, NY) and originally modified by Brigham and Women’s Hospital (Boston, Mass) for image segmentation. The segmentation protocol used by the Neuropsychiatric Imaging Research Laboratory was a modified version40-41 that has been previously described.42 Total cerebral volume was defined as the total white matter, gray matter, and ventricle volumes in both cerebral hemispheres.
All image analysts received extensive training, and reliability was established by repeated measurements on multiple MRIs before raters were approved to process study data. An ongoing reliability study ensured that the quality of volumetric analyses was maintained. Intraclass correlation coefficients attained were left hippocampus = 0.8, right hippocampus = 0.7, and total cerebral volume = 0.997.
DNA EXTRACTION AND GENOTYPING OF THE 5-HTTLPR
Subjects provided a blood sample for genetic testing. Genomic DNA was extracted by standard procedure (Puregene D-50K DNA Isolation Kit; Gentra, Minneapolis, Minn) from fresh or frozen samples of peripheral blood. Polymerase chain reaction amplification was used to generate a 484- and a 528-bp fragment corresponding to the short and long 5-HTTLPR alleles, respectively. This method22 and the subsequent modifications31 have been previously described. Subjects were thus classified as being homozygous for the long (L /L genotype) or short alleles (S/S genotype), or heterozygous (L /S genotype).
ANALYTIC STRATEGY
For all analyses, early-onset depression was defined a priori as depression developing at 50 years or younger; late-onset depression was defined as developing at 51 years or older.43 We used t tests and  2 tests to determine differences in demographic variables, genotype frequency, and hippocampal volumes first between subjects with depression and control subjects, then among the diagnostic categories of control subjects, subjects with early-onset depression, and subjects with late-onset depression. Hippocampal volumes were measured separately as total volume, right hippocampus, and left hippocampus. Analysis of covariance assessed hippocampal volumes using total cerebral volume as a within-subject factor and diagnosis, genotype, current age, and sex as between-subject factors. Because we were particularly interested in the interaction between diagnosis and genotype, an interaction term was included in these models.
As part of our a priori analytic plan to replicate previous research using similar analytic methods,21 analysis of covariance was used to examine the effect of diagnosis on hippocampal volume for each genotype separately. This was done after ensuring that hippocampal volumes were normally distributed and was only done for hippocampal measurements that were significantly associated with a genotypexdiagnosis interaction. These models controlled for total cerebral volume, current age, and sex. For models showing a statistically significant effect, defined as a P<.05, the least squares means procedure was used to assess for differences between diagnostic groups. Finally, in a post hoc analysis, subjects with depression were examined in general linear models where the association between hippocampal volumes and age of onset was examined as a continuous variable, while including an age of onset by genotype interaction and also controlling for total cerebral volume, sex, and current age. Separate models were examined within each genotype, controlling for the same predictors.
RESULTS
SAMPLE CHARACTERISTICS
There were 135 subjects with depression and 83 control subjects; these groups did not differ on demographic variables (Table 1). There were no significant differences in genotype frequency or hippocampal volumes between the depressed and control groups.
|
|
|
|
Table 1. Demographic and Clinical Data of Participants With and Without Depression*
|
|
|
The cohort with depression was subdivided into those with early-onset and late-onset depression, using age older than 50 years as the cutoff (72 subjects with early-onset depression, 63 subjects with late-onset depression) (Table 2). Subjects with early-onset and late-onset depression had no difference in sex representation or baseline depression severity as measured by the Montgomery-Asberg Depression Rating Scale38; however, the late-onset cohort was significantly older. There was no significant difference in genotype frequency among the diagnostic groups. Hippocampal volume differences were not statistically significant among diagnostic groups even after controlling for total cerebral volume.
|
|
|
|
Table 2. Demographic and Clinical Data of Participants With and Without Depression Dichotomized by Age of Depression Onset*
|
|
|
Differences in demographic data were also examined among the 5-HTTLPR genotypes. There were no differences in age (F2,217 = 2.03; P = .13) or sex (22 = 0.74; P = .69) among genotypes in the entire sample. Similar results were seen in the depressed cohort alone (age, F2,134 = 1.13; P = .33; sex, 22 = 0.26; P = .88), and no differences were seen among genotypes in depression severity on the Montgomery-Asberg Depression Rating Scale (F2,134 = 0.40; P = .67), age of depression onset (F2,134 = 1.98; P = .14), or the ratio of subjects with early-onset depression to subjects with late-onset depression (22 = 4.21; P = .12).
INTERACTIONS BETWEEN 5-HTTLPR GENOTYPE AND DIAGNOSIS
Multivariate models examined the relationship between hippocampal volumes, genotype, and diagnosis, including age, sex, and total cerebral volumes as covariates. A genotypexdiagnosis interaction term was also included in the models. Separate models were created for left, right, and total hippocampal volumes (Table 3). The interaction of genotype by diagnosis was statistically significant only in the right hippocampal volume model. There was a statistical trend for an association between genotype and total and left hippocampal volumes, but there were no statistically significant associations with diagnosis in these models.
|
|
|
|
Table 3. Full ANCOVA Models Examining Effects on Hippocampal Volumes*
|
|
|
In these models, the diagnosis variable trichotomized subjects into those with early-onset depression, late-onset depression, and control subjects. Multivariate models were also created wherein subjects were simply examined as subjects with depression or control subjects. In these models, neither genotype, diagnosis (depression or control), nor the diagnosisxgenotype interaction were statistically significant.
THE EFFECT OF DIAGNOSIS ON RIGHT HIPPOCAMPAL VOLUMES FOR INDIVIDUAL 5-HTTLPR GENOTYPES
Analysis of covariance models next examined right hippocampal volume as the outcome within each genotype, so separate models were created for subjects with L /L, L /S, and S/S genotypes. These examined the influence of diagnostic status on right hippocampal volumes while controlling for total cerebral volume, current age, and sex. Similar models were not created for left and total hippocampal volumes because full models (Table 3) did not show a significant interaction between genotype and diagnosis.
Depression status only significantly influenced right hippocampal volumes in subjects with the L /L genotype (F2,75 = 3.64; P = .03). The least squares means analysis found that subjects with late-onset depression had smaller right hippocampal volumes than did either subjects with early-onset depression (adjusted mean difference, 0.20 mL; P = .046) or control subjects (adjusted mean difference, 0.26 mL; P = .01). There was not a statistically significant difference between subjects with early-onset depression and control subjects (adjusted mean difference, 0.06 mL; P = .51).
In subjects with the S/S genotype, there was a statistical trend for an association between diagnostic status and right hippocampal volumes (F2,33 = 2.61; P = .09). There was no such association in subjects with the L /S genotype (F2,107 = 0.16; P = .86).
MODELS FOR EACH 5-HTTLPR GENOTYPE USING AGE OF ONSET AS A CONTINUOUS PREDICTOR
Previous models dichotomized subjects based on age of depression onset. As a post hoc analysis, we examined if age of onset itself was associated with hippocampal volumes for the different genotypes while controlling for current age, sex, and total cerebral volume. Only subjects with depression were included in these analyses because control subjects had no history of depression.
Initial models examined the effect of genotype and age of depression onset as predictors while including an interaction term for these 2 predictors and controlling for age, sex, and total cerebral volume. The age of onset by genotype interaction was statistically significant in all models (right hippocampal volume, F2,134 = 4.10; P = .02; left hippocampal volume, F2,134 = 3.29; P = .04; total hippocampal volume, F2,134 = 4.09; P = .02). Additionally, total cerebral volume was statistically significant in all models (right hippocampal volume, F1,134 = 5.54; P = .02; left hippocampal volume, F1,134 = 6.94; P = .01; total hippocampal volume, F1,134 = 7.56; P = .007). No other predictor was significantly associated with hippocampal volumes in any model.
The relationship between age of depression onset and hippocampal volumes was next considered within each genotype, while also controlling for age, sex, and total cerebral volume (statistical results for age of onset variables presented in Table 4). For subjects with depression with the L /L genotype, age of onset was negatively associated with total and right hippocampal volumes but not left. This would mean that later age of onset was associated with smaller total and right hippocampal volumes. There was no significant influence of age of onset on hippocampal volumes for subjects with depression with the L /S genotype.
|
|
|
|
Table 4. Association of Age of Depression Onset With Hippocampal Volumes by 5-HTTLPR Genotype*
|
|
|
For subjects with depression with the S/S genotype, age of onset was positively associated with total and right hippocampal volumes and exhibited a statistical trend for a positive association with the left hippocampal volume. This would indicate that an earlier onset of depression is associated with smaller hippocampal volumes.
5-HTTLPR GENOTYPE AND HIPPOCAMPAL VOLUMES IN SUBJECTS WITHOUT DEPRESSION
The control population without depression was examined separately in a post hoc analysis. It was thought that if an association between 5-HTTLPR genotype and hippocampal volumes was found in this population that it would indicate a general genetic susceptibility rather than a phenomenon specific to depression. When controlling for age, sex, and total cerebral volume, there was no association between genotype and any hippocampal measurement (total hippocampal volume, F2,82 = 0.23; P = .79; left hippocampal volume, F2,82 = 1.28; P = .28; right hippocampal volume, F2,82 = 0.16; P = .85).
COMMENT
Although others have examined the relationship between 5-HTTLPR genotype and hippocampal volumes in depression,21 to our knowledge this is the first study examining that question in an elderly population. We found no association between 5-HTTLPR and hippocampal volumes when the depressed cohort was examined as 1 group; however, we did find a significant interaction between diagnosis and genotype for the right hippocampal volume when subjects with depression were dichotomized based on age of depression onset. After controlling for age, sex, and total cerebral volume, subjects with a late onset of depression and L /L genotype exhibited smaller right hippocampal volumes than did control subjects or subjects with early-onset depression with that genotype. This finding is similar to a previous report associating smaller hippocampal volumes with the L /L genotype, although that report did not exclusively examine older subjects dichotomized based on age of onset.21
Post hoc analyses in subjects with depression examining age at onset as a continuous variable resulted in broader findings. The interaction between age of onset and genotype was statistically significant for all hippocampal volume measurements. When individual genotypes were examined, later age at onset in subjects with depression with the L /L genotype was associated with smaller right and total hippocampal volumes, while earlier age at onset was associated with smaller hippocampal volumes in subjects with depression with the S/S genotype. No relationship between age at onset and hippocampal volumes was found in subjects with the heterozygous genotype.
These findings are important because they expand our understanding of the pathophysiologic features of depression and the interaction between genetic and neuroanatomical contributors to depression. This association is critical, given how smaller volumes are associated with poorer outcomes of antidepressant therapy19, 44 and may contribute to the cognitive dysfunction seen in geriatric depression.
This report highlights the relevance of age at onset in an elderly population with depression. Elderly individuals with depression may have had multiple episodes of depression, starting earlier in life; alternatively, they may have had no psychiatric history, becoming depressed for the first time later in life. Several distinctions between these groups have been identified, such that subjects with early-onset depression are more likely to have a family history of psychiatric illness,45-46 while subjects with late-onset depression are more likely to have greater subcortical ischemic disease on MRI.47-48 These findings have been interpreted to be signs of different causes or risk factors for depression based on age at depression onset.
If there are different risk factors for depression based on age at depression onset, there may be different risk factors for smaller hippocampal volumes based on age at depression onset. Subjects with an earlier onset of depression who have a greater lifetime depression duration may have reduced hippocampal volumes6, 14 through repeated stress-induced increases in glucocorticoid levels, which have neurotoxic effects on hippocampal tissue.49 Alternatively, depression occurring for the first time in later life may be related to subcortical ischemia50 or may be a prodrome of dementia.20, 51 The hippocampus could thus be experiencing atrophy, as seen in Alzheimer disease.20 It may also be smaller because of ischemia impairing its cortical and subcortical connections; an association between subcortical ischemia and smaller hippocampal volumes has not been established in depression but has been seen in subcortical ischemic vascular dementia.52
Subcortical ischemic disease is one potential explanation for our finding of smaller hippocampal volumes in subjects with late-onset depression with the L /L genotype. The L /L genotype has been associated with greater platelet activation53 and greater increases in heart rate and blood pressure in response to stress.54 These factors may contribute to development of subcortical ischemic disease that is commonly seen in late-life depression,50 which could result in disconnection of the hippocampus from afferent and efferent structures, thus increasing the risk of depression.
Alternatively, the association between hippocampal volumes, depression, and the L /L genotype may be related to preclinical Alzheimer disease. Although there is debate about the role of 5-HTTLPR as a susceptibility factor for Alzheimer disease,55-57 an association between the L /L genotype and psychosis and agitation in Alzheimer disease has been reported.58-59 It is possible that the efficient synaptic removal of serotonin as a result of more efficient transcription of the serotonin transporter provided by the L /L genotype would result in behavioral problems60-62 or possible depression in the preclinical population.
It has also been hypothesized that the higher reuptake of serotonin resulting from the L /L genotype may cause a distinct vulnerability in the hippocampus to stress-induced neurotoxic effects of glucocorticoid.21 Our findings associating L /L genotype and smaller hippocampal volumes with a later onset of depression, thus possibly a shorter duration of depression, argues against this hypothesis. However, as age of depression onset does not necessarily equate with duration of depression, this hypothesis may still be correct.
The report of an earlier age at onset being associated with smaller hippocampal volumes in subjects with depression with the S/S genotype should be viewed with caution. The post hoc analyses of this genotype found an association between earlier age at onset and smaller hippocampal volumes but were complicated by a relatively small number of subjects exhibiting the S/S genotype. This finding is biologically plausible because the S/S genotype moderates the influence of stressful life events on the development of depression.63 Thus, individuals with the S/S genotype who underwent multiple stressful life events would be expected to have a greater lifetime duration of depression, which may impact hippocampal volume6, 14 through elevated glucocorticoid levels,49 decreases in brain-derived neurotrophic factor,64 and decreases in neurogenesis.65 Replication of this finding is needed because this theory is dependent on depression duration and history of antidepressant therapy.
The primary limitation of this study is its case-control design, which is sensitive to population stratification. This may be seen in genotype frequency; although there was no difference in genotype frequency among diagnostic groups, there was a comparatively small number of subjects with the S/S genotype. It could be argued that a superior study design would have included equal numbers of subjects across genotypes, but this would involve increasing the sample size significantly. Another limitation is our age at onset variable, which was provided by subject self-report. This variable is not a surrogate for depression duration or treatment, which would include the number, duration, and severity of past episodes and history of treatment and is a subjective recollection rather than data supported by the medical record. It also does not ensure that such first episodes would meet diagnostic criteria for major depression. Future studies should include better measures for duration of total depressive episodes. Finally, although all subjects met criteria for a current diagnosis of active major depression, there was no information on how long subjects had taken antidepressants prior to the MRI.
It is also possible other factors not examined herein contributed to smaller hippocampal volumes. The apolipoprotein E (APOE) genotype, a risk factor for Alzheimer disease, is one possible contributing factor; however, previous reports have failed to demonstrate a cross-sectional association between APOE status and hippocampal volumes in late-life depression.66 Given the potential association between L /L genotype and subcortical ischemia, it may be reasonable to study the relationship between subcortical lesions and hippocampal volumes. Other contributors, including more complex gene-gene interactions are also possible.
In summary, this study reports an association between the L /L genotype of the 5-HTTLPR and smaller hippocampal volumes in late-onset depression and a tentative association between the S/S genotype and earlier age of depression onset. Further research is needed to unravel the association between genotype and psychosocial stressors in the elderly population and also to determine how genotype and brain morphological characteristics may contribute to treatment outcomes in elderly individuals with depression.
AUTHOR INFORMATION
Correspondence: Warren D. Taylor, MD, Department of Psychiatry, Duke University Medical Center, DUMC Box 3903, Durham, NC 27710 (taylo066{at}mc.duke.edu).
Submitted for Publication: April 12, 2004; final revision received September 14, 2004; accepted October 7, 2004.
Funding/Support: This study was supported by grants K23 MH 65939, R01 MH54846, and P50 MH60451 from the National Institute of Mental Health, Bethesda, Md.
Acknowledgment: We thank Daniel Greenberg, MA, for contributions to the development of the hippocampus volume–measurement procedure; Denise Fetzer, MA, and Cynthia Key for magnetic resonance image analysis; and Carl Pieper, DrPH, for advice on statistical methods.
Author Affiliations: Departments of Psychiatry (Drs Taylor, Steffens, and Krishnan and Ms Payne), Radiology (Dr MacFall), and Molecular Genetics and Microbiology (Drs Marchuk and Svenson), Duke University Medical Center, Durham, NC.
REFERENCES
| |
1. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000;48:813-829.
FULL TEXT
|
ISI
| PUBMED
2. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception, II: implications for major psychiatric disorders. Biol Psychiatry. 2003;54:515-528.
FULL TEXT
|
ISI
| PUBMED
3. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception, I: the neural basis of normal emotion perception. Biol Psychiatry. 2003;54:504-514.
FULL TEXT
|
ISI
| PUBMED
4. Krishnan KR, Doraiswamy PM, Figiel GS, Husain MM, Shah SA, Na C, Boyko OB, McDonald WM, Nemeroff CB, Ellinwood EH Jr. Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci. 1991;3:387-391.
FREE FULL TEXT
5. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996;93:3908-3913.
FREE FULL TEXT
6. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci. 1999;19:5034-5043.
FREE FULL TEXT
7. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: controlled magnetic resonance imaging study. Br J Psychiatry. 1998;172:527-532.
FREE FULL TEXT
8. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000;157:115-117.
FREE FULL TEXT
9. Frodl T, Meisenzahl EM, Zetzsche T, Born C, Groll C, Jager M, Leinsinger G, Bottlender R, Hahn K, Moller HJ. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry. 2002;159:1112-1118.
FREE FULL TEXT
10. Axelson DA, Doraiswamy PM, McDonald WM, Boyko OB, Tupler LA, Patterson LJ, Nemeroff CB, Ellinwood EH Jr, Krishnan KR. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 1993;47:163-173.
FULL TEXT
|
ISI
| PUBMED
11. Posener JA, Wang L, Price JL, Gado MH, Province MA, Miller MI, Babb CM, Csernansky JG. High-dimensional mapping of the hippocampus in depression. Am J Psychiatry. 2003;160:83-89.
FREE FULL TEXT
12. Vakili K, Pillay SS, Lafer B, Fava M, Renshaw PF, Bonello-Cintron CM, Yurgelun-Todd DA. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry. 2000;47:1087-1090.
FULL TEXT
|
ISI
| PUBMED
13. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A. 2003;100:1387-1392.
FREE FULL TEXT
14. Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003;160:1516-1518.
FREE FULL TEXT
15. Bell-McGinty S, Butters MA, Meltzer CC, Greer PJ, Reynolds CF III, Becker JT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry. 2002;159:1424-1427.
FREE FULL TEXT
16. Steffens DC, Byrum CE, McQuoid DR, Greenberg DL, Payne ME, Blitchington TF, MacFall JR, Krishnan KR. Hippocampal volume in geriatric depression. Biol Psychiatry. 2000;48:301-309.
FULL TEXT
|
ISI
| PUBMED
17. Pantel J, Schroder J, Essig M, Popp D, Dech H, Knopp MV, Schad LR, Eysenbach K, Backenstrass M, Friedlinger M. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J Affect Disord. 1997;42:69-83.
FULL TEXT
|
ISI
| PUBMED
18. Ashtari M, Greenwald BS, Kramer-Ginsberg E, Hu J, Wu H, Patel M, Aupperle P, Pollack S. Hippocampal/amygdala volumes in geriatric depression. Psychol Med. 1999;29:629-638.
FULL TEXT
|
ISI
| PUBMED
19. Hsieh M-H, McQuoid DR, Levy RM, Payne ME, MacFall JR, Steffens DC. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry. 2002;17:519-525.
FULL TEXT
|
ISI
| PUBMED
20. Steffens DC, Payne ME, Greenberg DL, Byrum CE, Welsh-Bohmer KA, Wagner HR, MacFall JR. Hippocampal volume and incident dementia in geriatric depression. Am J Geriatr Psychiatry. 2002;10:62-71.
FULL TEXT
|
ISI
| PUBMED
21. Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schule C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Moller HJ. Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry. 2004;61:177-183.
FREE FULL TEXT
22. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
FREE FULL TEXT
23. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621-2624.
ISI
| PUBMED
24. Owens MJ, Nemeroff CB. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem. 1994;40:288-295.
FREE FULL TEXT
25. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role of susceptibility to affective disorders. Mol Psychiatry. 1996;1:453-460.
ISI
| PUBMED
26. Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, Hilger E, Thierry N, Konstantinidis A, Winkler D, Fuchs K, Sieghart W, Aschauer H, Ackenheil M, Bondy B, Kasper S. A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry. 2003;8:942-946.
FULL TEXT
|
ISI
| PUBMED
27. Minov C, Baghai TC, Schule C, Zwanzger P, Schwarz MJ, Zill P, Rupprecht R, Bondy B. Serotonin-2A-receptor and transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett. 2001;303:119-122.
FULL TEXT
|
ISI
| PUBMED
28. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol Psychiatry. 2002;7:95-99.
FULL TEXT
|
ISI
| PUBMED
29. Gorwood P, Batel P, Ades J, Hamon M, Boni C. Serotonin gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry. 2000;48:259-264.
FULL TEXT
|
ISI
| PUBMED
30. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, Carroll BJ. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport. 2000;11:215-219.
ISI
| PUBMED
31. Steffens DC, Svenson I, Marchuk DA, Levy RM, Hays JC, Flint EP, Krishnan KR, Siegler IC. Allelic differences in the serotonin transporter-linked polymorphic region in geriatric depression. Am J Geriatr Psychiatry. 2002;10:185-191.
FULL TEXT
|
ISI
| PUBMED
32. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ. Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry. 2002;7:1115-1119.
FULL TEXT
|
ISI
| PUBMED
33. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, Reynolds CF, Kupfer DJ. Allelic variation in the serotonin transporter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology. 2000;23:587-590.
FULL TEXT
|
ISI
| PUBMED
34. Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, Rosenbaum JF, Fava M. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry. 2003;54:879-883.
FULL TEXT
|
ISI
| PUBMED
35. Bellivier F, Szoke A, Henry C, Lacoste J, Bottos C, Nosten-Bertrand M, Hardy P, Rouillon F, Launay JM, Laplanche JL, Leboyer M. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry. 2000;48:319-322.
FULL TEXT
|
ISI
| PUBMED
36. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry. 1981;38:381-389.
FREE FULL TEXT
37. Landerman R, George LK, Campbell RT, Blazer DG. Alternative models of the stress buffering hypothesis. Am J Psychiatry. 1989;17:625-642.
FULL TEXT
|
ISI
| PUBMED
38. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
FREE FULL TEXT
39. MacFall JR, Byrum CE, Parashos I, Early B, Charles HC, Chittilla V, Boyko OB, Upchurch L, Krishnan KR. Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods. Psychiatry Res. 1994;55:167-177.
FULL TEXT
|
ISI
| PUBMED
40. Kikinis R, Shenton ME, Gerig G, Martin J, Anderson M, Metcalf D, Guttmann CR, McCarley RW, Lorensen W, Cline H, Jolesz FA. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging. 1992;2:619-629.
41. Byrum CE, MacFall JR, Charles HC, Chitilla VR, Boyko OB, Upchurch L, Smith JS, Rajagopalan P, Passe T, Kim D, Xanthakos S, Ranga K, Krishnan R. Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. Psychiatry Res. 1996;67:215-234.
FULL TEXT
|
ISI
| PUBMED
42. Payne ME, Fetzer DL, MacFall JR, Provenzale JM, Byrum CE, Krishnan KRR. Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res. 2002;115:63-77.
FULL TEXT
|
ISI
| PUBMED
43. Krishnan KR, Hays JC, Tupler LA, George LK, Blazer DG. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry. 1995;152:785-788.
FREE FULL TEXT
44. Frodl T, Meisenzahl EM, Zetzsche T, Hohne T, Banac S, Schorr C, Jager M, Leinsinger G, Bottlender R, Reiser M, Moller HJ. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry. 2004;65:492-499.
ISI
| PUBMED
45. Brodaty H, Luscombe G, Parker G, Wilhelm K, Hickie I, Austin MP, Mitchell P. Early and late onset depression in old age: different aetiologies, same phenomenology. J Affect Disord. 2001;66:225-236.
FULL TEXT
|
ISI
| PUBMED
46. Mendlewicz J. The age factor in depressive illness: some genetic considerations. J Gerontol. 1976;31:300-303.
ABSTRACT
47. Krishnan KR, Goli V, Ellinwood EH, France RD, Blazer DZ, Nemeroff CB. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry. 1988;23:519-522.
FULL TEXT
|
ISI
| PUBMED
48. Salloway S, Malloy P, Kohn R, Gillard E, Duffy J, Rogg J, Tung G, Richardson E, Thomas C, Westlake R. MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology. 1996;46:1567-1574.
FREE FULL TEXT
49. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 1990;10:2897-2902.
ABSTRACT
50. Krishnan KR, Tayor WD, McQuoid DR, MacFall JR, Payne ME, Provenzale JM, Steffens DC. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry. 2004;55:390-397.
FULL TEXT
|
ISI
| PUBMED
51. Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry. 1993;34:141-145.
FULL TEXT
|
ISI
| PUBMED
52. Du AT, Schuff N, Laakso MP, Zhu XP, Jagust WJ, Yaffe K, Kramer JH, Miller BL, Reed BR, Norman D, Chui HC, Weiner MW. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology. 2002;58:1635-1641.
FREE FULL TEXT
53. Whyte EM, Pollock BG, Wagner WR, Mulsant BH, Ferrell RE, Mazumdar S, Reynolds CF III. Influence of serotonin-transporter linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry. 2001;158:2074-2076.
FREE FULL TEXT
54. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med. 2001;63:300-305.
FREE FULL TEXT
55. Hu M, Retz W, Baader M, Pesold B, Adler G, Henn FA, Rosler M, Thome J. Promoter polymorphism of the 5-HT transporter and Alzheimer's disease. Neurosci Lett. 2000;294:63-65.
FULL TEXT
|
ISI
| PUBMED
56. Li T, Holmes C, Sham PC, Vallada H, Birkett J, Kirov G, Lesch KP, Powell J, Lovestone S, Collier D. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport. 1997;8:683-686.
ISI
| PUBMED
57. Zill P, Padberg F, de Jonge S, Hampel H, Burger K, Stubner S, Boetsch T, Jurgen Moller H, Ackenheil M, Bondy B. Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients. Neurosci Lett. 2000;284:113-115.
FULL TEXT
|
ISI
| PUBMED
58. Sweet RA, Pollock BG, Sukonick DL, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE. The 5-HTTLPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int Psychogeriatr. 2001;13:401-409.
FULL TEXT
|
ISI
| PUBMED
59. Sukonick DL, Pollock BG, Sweet RA, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE. The 5-HTTLPR*S/*L polymorphism and aggressive behavior in Alzheimer disease. Arch Neurol. 2001;58:1425-1428.
FREE FULL TEXT
60. Mintzer J, Brawman-Mintzer O, Mirski DF, Unger R, Nietert P, Meeks A, Sampson R. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation. Biol Psychiatry. 1998;44:918-921.
FULL TEXT
|
ISI
| PUBMED
61. Procter AW, Francis PT, Stratmann GC, Bowen DM. Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochem Res. 1992;17:917-922.
FULL TEXT
|
ISI
| PUBMED
62. Lanctot KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA. Central serotonergic activity is related to aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology. 2002;27:646-654.
ISI
| PUBMED
63. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
FREE FULL TEXT
64. Mamounas LA, Blue ME, Siuciak JA, Altar CA. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci. 1995;15:7929-7939.
ABSTRACT
65. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E. Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci. 1997;17:2492-2498.
FREE FULL TEXT
66. Kim do H, Payne ME, Levy RM, MacFall JR, Steffens DC. APOE genotype and hippocampal volume change in geriatric depression. Biol Psychiatry. 2002;51:426-429.
FULL TEXT
|
ISI
| PUBMED
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Modification by Two Genes of Associations Between General Somatic Health and Incident Depressive Syndrome in Older People
Kim et al.
Psychosom. Med. 2009;71:286-291.
ABSTRACT
| FULL TEXT
Hippocampal Morphology and Distinguishing Late-Onset From Early-Onset Elderly Depression
Ballmaier et al.
Am. J. Psychiatry 2008;165:229-237.
ABSTRACT
| FULL TEXT
Cerebral Cortical Gray Matter Overgrowth and Functional Variation of the Serotonin Transporter Gene in Autism
Wassink et al.
Arch Gen Psychiatry 2007;64:709-717.
ABSTRACT
| FULL TEXT
Association of the Brain-Derived Neurotrophic Factor Val66Met Polymorphism With Reduced Hippocampal Volumes in Major Depression
Frodl et al.
Arch Gen Psychiatry 2007;64:410-416.
ABSTRACT
| FULL TEXT
|
